You use Therapeutics in Dermatology on a regular basis and you are pleased with it?

Then help us improve it by

   making a donation here!

Therapeutics in Dermatology
A reference textbook in dermatology

  Health professionals

Home > English > Book > Drugs >


6 June 2012, by DELAPORTE E. & PIETTE F.

Sulfasalazine (Salazopyrin®) was launched in France en 1958. Its current indications are: ulcerative colitis, colic Crohn’s disease and rheumatoid arthritis. This molecule has few uses in a dermatological setting.

× N.B. : This limited content is for the general public. If you are a health professional, click here to register for free and gain access to a dedicated deeper content.
If you already have an account, log in!

Follow us


René Touraine Foundation